Gunnar Brobert
7PUBLICATIONS
22CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Mar 26, 2024
Challenges and lessons learned from a long-term postauthorisation safety study programme of rivaroxaban in Europe.Gunnar Brobert, Ana Ruigomez, Tania Schink
|Feb 16, 2023
Safety and effectiveness of rivaroxaban for prevention of stroke in patients with nonvalvular atrial fibrillation: analysis of routine clinical data from four countries.Luis Alberto García Rodríguez, Ana Ruigómez, Tania Schink
|Feb 01, 2023
Time Trends in Patient Characteristics of New Rivaroxaban Users with Atrial Fibrillation in Germany and the Netherlands.Annemarie Voss, Elisabeth Smits, Karin M A Swart
|Nov 09, 2022
Acute Kidney Injury in Patients with Non-Valvular Atrial Fibrillation Treated with Rivaroxaban or Warfarin: A Population-Based Study from the United Kingdom.Antonio González-Pérez, Yanina Balabanova, María E Sáez
|Jun 10, 2022
Time Trends and Treatment Pathways in Prescribing Individual Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation: An Observational Study of More than Three Million Patients from Europe and the United States.Pareen Vora, Henry Morgan Stewart, Beth Russell
|Oct 03, 2020
Validation of venous thromboembolism diagnoses in patients receiving rivaroxaban or warfarin in The Health Improvement Network.Ana Ruigómez, Gunnar Brobert, Pareen Vora
Pageof 2
Frequent Collaborators
5 joint publications
Luis Alberto García-Rodríguez
5 joint publications
Yanina Balabanova
4 joint publications
Tania Schink
4 joint publications
Ron M C Herings
4 joint publications
Pareen Vora
4 joint publications
Kiliana Suzart-Woischnik
3 joint publications
Elisabeth Smits
3 joint publications
Ana Ruigomez
3 joint publications
Annemarie Voss
2 joint publications
Leif Friberg
